Real-world clinical outcomes of immune checkpoint inhibitors beyond 2 Years in patients with non-small cell lung cancer: A multicenter retrospective study
Real-world clinical outcomes of immune checkpoint inhibitors beyond 2 Years in patients with non-small cell lung cancer: A multicenter retrospective study. // International Journal of Lung Cancer. – URL: https://www.sciencedirect.com/science/article/pii/S3117504X2600046X?dgcid=rss_sd_all
Real-world clinical outcomes of immune checkpoint inhibitors beyond 2 Years in patients with non-small cell lung cancer: A multicenter retrospective study. International Journal of Lung Cancer. https://www.sciencedirect.com/science/article/pii/S3117504X2600046X?dgcid=rss_sd_all
“Real-world clinical outcomes of immune checkpoint inhibitors beyond 2 Years in patients with non-small cell lung cancer: A multicenter retrospective study.” International Journal of Lung Cancer.
@article{article89537,
title = {Real-world clinical outcomes of immune checkpoint inhibitors beyond 2 Years in patients with non-small cell lung cancer: A multicenter retrospective study},
journal = {International Journal of Lung Cancer},
url = {https://www.sciencedirect.com/science/article/pii/S3117504X2600046X?dgcid=rss_sd_all}
}